What is photodynamic therapy?
Photodynamic therapy (PDT) is a treatment that uses a light-sensitive medicine together with a particular type of light to destroy cancer cells and some precancerous cells. Neither the medicine nor the light does much harm on its own. It is the combination of the two, together with oxygen in the tissue, that kills the cells.
The light-sensitive medicine, called a photosensitiser, is either applied to the skin as a cream or given into a vein. It builds up in abnormal cells more than in healthy ones. After a waiting period, light of a specific wavelength is shone on the area. The light activates the medicine, which produces a toxic form of oxygen that destroys the cells.
PDT is used most often for skin cancers and precancers on the surface of the skin, such as superficial basal cell carcinoma and Bowen disease. With an internal light source passed through an endoscope, it is also used for some cancers of the oesophagus, bile ducts and airways, usually to relieve symptoms.
A brief history
The idea that light and certain chemicals together could kill cells was first described in Germany around 1900. Modern PDT began in the 1970s, when Thomas Dougherty and colleagues in the United States used a light-sensitive medicine derived from blood pigments to treat tumours. The first approved photosensitiser, porfimer sodium, was licensed in the 1990s. Creams containing aminolevulinic acid or its methyl ester then made PDT a common treatment in dermatology.
1. Key facts at a glance
| Feature | Details |
|---|---|
| Type of treatment | Light-activated drug treatment (local and ablative) |
| Main uses | Superficial basal cell carcinoma, Bowen disease, actinic keratosis; some oesophageal, bile duct and lung cancers |
| Skin PDT | Cream applied for about 3 hours, then light for 10-20 minutes |
| Internal PDT | Medicine into a vein, then light through an endoscope 1-3 days later |
| Setting | Usually outpatient |
| Main side effects | Pain or burning during light treatment, redness, swelling, crusting; sensitivity to light after internal PDT |
| Scarring | Usually minimal on the skin |
2. How it works
Three ingredients
| Ingredient | Role |
|---|---|
| Photosensitiser | Builds up in abnormal cells and absorbs light |
| Light | Usually red light, which penetrates tissue best, or daylight for some skin conditions |
| Oxygen | Turned into a reactive form that damages cells |
Killing the cells
When the activated photosensitiser reacts with oxygen, it forms a short-lived, highly reactive form of oxygen. This damages the cell’s membranes and internal structures, causing it to die. PDT also damages small blood vessels feeding the tumour and can provoke an immune response against it.
Limited depth
Light can travel only a few millimetres into tissue. This is why PDT works best for thin, superficial cancers. Thicker tumours may not be fully treated.
Common photosensitisers
| Medicine | How it is given | Typical use |
|---|---|---|
| Methyl aminolevulinate (MAL) | Cream | Skin cancers and precancers |
| Aminolevulinic acid (ALA) | Cream or gel | Skin precancers and some skin cancers |
| Porfimer sodium | Into a vein | Oesophageal, lung and bile duct cancers |
| Temoporfin | Into a vein | Some head and neck cancers in Europe |
3. Who it is for
Conditions treated
| Condition | Role of PDT |
|---|---|
| Basal cell carcinoma | Superficial and some thin nodular types, especially where good cosmetic results matter |
| Bowen disease | A first-line option, particularly for large patches or areas that heal poorly, such as the lower leg |
| Perihilar cholangiocarcinoma | To help keep bile ducts open and control the tumour when surgery is not possible |
| Oesophageal adenocarcinoma | To relieve swallowing problems from tumours that block the oesophagus |
| Oesophageal squamous cell carcinoma | Similar use for blockage, or for very early cancers in some centres |
| Lung squamous cell carcinoma | Very early cancers in the central airways, or to clear blocked airways |
When PDT may be a good choice for skin cancer
| Situation | Reason |
|---|---|
| Multiple or large thin lesions | A wide area can be treated at once |
| Areas where healing is slow | Such as the lower legs |
| Cosmetically sensitive sites | Usually leaves little or no scar |
| People who prefer to avoid surgery | A non-surgical option |
When PDT is not suitable
PDT is not suitable for thick or deeply invasive skin cancers, aggressive types of basal cell carcinoma, melanoma, or cancers in areas such as the eyelid margin. It is also avoided in people with porphyria, a rare condition that causes sensitivity to light.
4. Before treatment
Skin PDT
| Step | Why it is done |
|---|---|
| Diagnosis | Biopsy or clinical assessment to confirm the type of lesion |
| Preparation | Crusts and scales are gently removed so the cream can penetrate |
| Medicines check | Some medicines increase light sensitivity |
| Plan | One or two treatment sessions, often a week apart |
Internal PDT
| Step | Why it is done |
|---|---|
| Scans and endoscopy | Show the position and extent of the tumour |
| Blood tests | General fitness |
| Light-protection plan | Arranging clothing, curtains and home routines for the weeks after |
5. What to expect: step by step
Skin PDT
| Step | What happens |
|---|---|
| 1. Preparation | The area is cleaned and lightly scraped |
| 2. Cream | The photosensitiser cream is applied |
| 3. Dressing | A light-proof dressing is placed over it |
| 4. Wait | About 3 hours |
| 5. Light | The dressing is removed and red light is shone on the area for 10-20 minutes |
| 6. Dressing again | The area is covered for a day or two |
Daylight PDT
For thin precancers on the face and scalp, cream can be applied in the clinic and you then spend about 2 hours outdoors in daylight. This is usually much less painful than red-light PDT.
Internal PDT
| Step | What happens |
|---|---|
| 1. Injection | The photosensitiser is given into a vein |
| 2. Wait | Usually 1-3 days while it builds up in the tumour |
| 3. Endoscopy | A thin flexible tube is passed to the tumour under sedation |
| 4. Light | A fibre carries laser light to the tumour |
| 5. Recovery | Usually home the same or next day |
| 6. Review | A further endoscopy may remove dead tissue |
Managing pain during skin PDT
Pain during the light stage is the most common reason people find skin PDT difficult. It is usually worst in the first few minutes and on the face and scalp. The team can pause the light, use a cool air fan or water spray, or give a local anaesthetic injection.
Pain usually settles quickly once the light stops. Daylight PDT, where it is suitable, is much more comfortable because the light dose builds up gradually.
6. Side effects and risks
Skin PDT
| Side effect | What to expect |
|---|---|
| Pain or burning | During light treatment; cooling fans, water sprays or local anaesthetic can help |
| Redness and swelling | For a few days |
| Crusting and weeping | Heals over 2-6 weeks |
| Skin colour change | Sometimes lighter or darker patches |
| Scarring | Uncommon |
Internal PDT
| Side effect | What to expect |
|---|---|
| Sensitivity to light | Skin and eyes are very sensitive for several weeks after porfimer sodium |
| Chest pain or swallowing pain | After treatment of the oesophagus |
| Narrowing (stricture) | Can occur as the area heals |
| Coughing up dead tissue | After airway treatment |
| Infection of the bile ducts | After biliary PDT |
Protecting yourself from light
After internal PDT, your skin can burn badly in sunlight or bright indoor light. For several weeks you need to cover your skin, wear dark glasses and avoid direct sunlight and strong lamps. Normal indoor light is fine and helps the medicine break down. Sunscreen does not protect against this reaction.
7. Results and outlook
| Study | Main finding |
|---|---|
| Superficial basal cell carcinoma, 601 patients | At 1 year, 73% of patients treated with MAL-PDT were tumour-free, compared with 83% with imiquimod cream and 80% with fluorouracil cream (Arits et al., 2013) |
| Nodular basal cell carcinoma, 5-year follow-up | Surgery cleared more cancers (96% versus 76% with lasting response), but PDT gave better cosmetic results (87% versus 54% excellent or good) (Rhodes et al., 2007) |
| Inoperable cholangiocarcinoma, 39 patients | Adding PDT to stenting extended median survival from 98 days to 493 days and improved bile drainage and quality of life (Ortner et al., 2003) |
What the results mean
For superficial skin cancers, PDT is effective and gives excellent cosmetic results, but it is somewhat less likely than surgery or some creams to clear the cancer permanently. It is therefore a good choice when appearance, healing or the number of lesions matters most. For bile duct and oesophageal cancers, PDT is usually used to control symptoms rather than to cure.
8. Recovery and aftercare
| Tip | Why |
|---|---|
| Keep the area dry and covered for 24-48 hours | Helps healing after skin PDT |
| Use simple painkillers if needed | Eases soreness |
| Avoid picking crusts | Reduces scarring |
| Protect from sun | Treated skin is sensitive |
| Follow light-protection rules after internal PDT | Prevents burns |
| Attend follow-up | Checks whether the area has cleared |
Caring for treated skin
As the skin heals, it may weep, crust and then peel, much like a graze. Washing gently with water, patting dry and applying a plain moisturiser or petroleum jelly once crusts form can help. A simple non-stick dressing protects the area from clothing. If the area becomes increasingly painful, hot or swollen, or produces pus, contact your team, as this may be infection.
Eating after oesophageal PDT
After PDT to the oesophagus, swallowing may be sore for a week or two. Soft or liquid foods are easiest at first, moving back to a normal diet as comfort allows. Tell your team if swallowing becomes harder again later, as a narrowing can often be stretched.
Follow-up
After skin PDT, the area is checked after about 3 months. Any remaining lesion may be treated again with PDT or a different method. People who have had one skin cancer are at higher risk of others, so regular skin checks and sun protection are important.
Living well after skin cancer
Most skin cancers treated with PDT are linked to sun exposure over many years. Using a broad-spectrum sunscreen, wearing a hat and covering up in strong sun all help reduce the chance of new lesions. Check your skin every month or so and show your doctor any new or changing spot.
9. Alternatives
| Alternative | When it is considered |
|---|---|
| Surgical excision | Most skin cancers; most reliable clearance |
| Mohs micrographic surgery | High-risk skin cancers on the face |
| Cryosurgery | Small, superficial skin lesions |
| Creams such as imiquimod or fluorouracil | Superficial skin cancers and precancers |
| Brachytherapy | Some oesophageal blockages and skin cancers |
| Palliative radiotherapy | To relieve symptoms of advanced cancers |
10. Frequently asked questions
| Question | Answer |
|---|---|
| Does PDT hurt? | Skin PDT can sting or burn during light treatment; pain relief helps |
| Will it leave a scar? | Usually little or none on the skin |
| How many sessions will I need? | Often one or two for skin lesions |
| Can I drive home? | After skin PDT usually yes; after sedation, no |
| Can PDT treat melanoma? | No |
| How long am I sensitive to light? | A day or two after skin PDT; several weeks after internal PDT |
| Is PDT radiotherapy? | No, it uses light, not radiation |
| Can I wear make-up afterwards? | Usually once the skin has healed |
| Can I go to work afterwards? | Usually the next day after skin PDT, if the dressing is comfortable |
| Does PDT work on the scalp? | Yes, it is often used there for precancers |
| Can PDT be repeated? | Yes, it can be repeated on the same area |
11. Questions to ask your care team
- Why is PDT a good option for me?
- How likely is it to clear the cancer compared with surgery?
- How many sessions will I need?
- How will my pain be managed?
- What light precautions should I take afterwards?
- What happens if the cancer comes back?
Resources
- Arits, A.H. et al. (2013) ‘Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial’, The Lancet Oncology, 14(7), pp. 647-654.
- Ortner, M.E. et al. (2003) ‘Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study’, Gastroenterology, 125(5), pp. 1355-1363.
- Rhodes, L.E. et al. (2007) ‘Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma’, Archives of Dermatology, 143(9), pp. 1131-1136.
- National Cancer Institute (2026) Photodynamic Therapy to Treat Cancer. Available at: https://www.cancer.gov/about-cancer/treatment/types/photodynamic-therapy (Accessed: October 2026).
- National Cancer Institute (2026) Skin Cancer Treatment (PDQ) – Health Professional Version. Available at: https://www.cancer.gov/types/skin/hp/skin-treatment-pdq (Accessed: October 2026).
Prepared by the editorial team, October 2026.